AFFX Affymetrix, Inc.

Affymetrix, Inc. (Nasdaq:AFFX) today announced that company management will provide an overview of Affymetrix and outline future growth opportunities at two upcoming financial conferences. Doug Farrell, Vice President of Investor Relations, will present at the JPMorgan Small/Mid Cap Conference in Boston, MA. A live transmission of the presentation will take place at 10:20 a.m. PT (1:20 p.m. ET) on Wednesday, November 15, 2006. An archived webcast will be available for 30 days. Greg Schiffman, Executive Vice President and Chief Financial Officer, will present at the Lehman Small Cap Conference in Dana Point, CA. A live transmission of the presentation will take place at 11:20 a.m. PT (2:20 p.m. ET) on Friday, November 17, 2006. An archived webcast will be available for 30 days. To access the live webcast or archived presentation, find the "Investors" link in the "Resources for" drop-down menu on www.affymetrix.com. About Affymetrix Affymetrix scientists invented the world's first high-density microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip(R) technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,400 systems have been installed around the world and more than 7,000 peer-reviewed papers have been published using the technology. Affymetrix' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health. Affymetrix is headquartered in Santa Clara, Calif., with manufacturing facilities in Sacramento, Calif., and Bedford, Mass. The company maintains important sales and marketing operations in Europe and Asia and has about 1,100 employees worldwide. For more information about Affymetrix, please visit the company's website at www.affymetrix.com. NOTE: Affymetrix, the Affymetrix logo, and GeneChip are registered trademarks owned or used by Affymetrix Inc. Affymetrix, Inc. (Nasdaq:AFFX) today announced that company management will provide an overview of Affymetrix and outline future growth opportunities at two upcoming financial conferences. Doug Farrell, Vice President of Investor Relations, will present at the JPMorgan Small/Mid Cap Conference in Boston, MA. A live transmission of the presentation will take place at 10:20 a.m. PT (1:20 p.m. ET) on Wednesday, November 15, 2006. An archived webcast will be available for 30 days. Greg Schiffman, Executive Vice President and Chief Financial Officer, will present at the Lehman Small Cap Conference in Dana Point, CA. A live transmission of the presentation will take place at 11:20 a.m. PT (2:20 p.m. ET) on Friday, November 17, 2006. An archived webcast will be available for 30 days. To access the live webcast or archived presentation, find the "Investors" link in the "Resources for" drop-down menu on www.affymetrix.com. About Affymetrix Affymetrix scientists invented the world's first high-density microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip(R) technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,400 systems have been installed around the world and more than 7,000 peer-reviewed papers have been published using the technology. Affymetrix' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health. Affymetrix is headquartered in Santa Clara, Calif., with manufacturing facilities in Sacramento, Calif., and Bedford, Mass. The company maintains important sales and marketing operations in Europe and Asia and has about 1,100 employees worldwide. For more information about Affymetrix, please visit the company's website at www.affymetrix.com. NOTE: Affymetrix, the Affymetrix logo, and GeneChip are registered trademarks owned or used by Affymetrix Inc.